14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RGLS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Monday for Regulus Therapeutics Inc. stock after gaining 3.29%
(Updated on Apr 22, 2024)

Sell candidate since Apr 18, 2024 Loss -0.90% PDF

The Regulus Therapeutics Inc. stock price gained 3.29% on the last trading day (Monday, 22nd Apr 2024), rising from $2.13 to $2.20. During the last trading day the stock fluctuated 8.13% from a day low at $2.09 to a day high of $2.26. The price has fallen in 6 of the last 10 days and is down by -17.6% for this period. Volume fell on the last day by -96 thousand shares and in total, 127 thousand shares were bought and sold for approximately $279.32 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.16 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 110.38% during the next 3 months and, with a 90% probability hold a price between $4.54 and $7.01 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

RGLS Signals & Forecast

There are few to no technical positive signals at the moment. The Regulus Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $2.43 and $2.38. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 28, 2024, and so far it has fallen -23.61%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Regulus Therapeutics Inc. stock

Regulus Therapeutics Inc. finds support from accumulated volume at $2.13 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.170 between high and low, or 8.13%. For the last week the stock has had daily average volatility of 9.77%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RGLS) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Regulus Therapeutics Inc. to open at $2.18, and during the day (based on 14 day Average True Range), to move between $1.96 and $2.44, which gives a possible trading interval of +/-$0.241 (+/-10.94%) up or down from last closing price. If Regulus Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 21.88% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.13 (3.18%) than the resistance at $2.36 (7.27%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Regulus Therapeutics Inc. stock A Buy?

The Regulus Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Regulus Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.658 Sell Candidate Unchanged

Predicted Opening Price for Regulus Therapeutics Inc. of Tuesday, April 23, 2024

Fair opening price April 23, 2024 Current price
$2.18 ( 0.758%) $2.20

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RGLS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.35 6.97 %
R2 2.29 4.02 %
R1 2.25 2.19 %
Current price: 2.20
Support S1 2.12 -3.71 %
S2 2.08 -5.53 %
S3 2.01 -8.48 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.45 11.14 %
R2 2.43 10.45 %
R1 2.36 7.27 %
Current price 2.20
Support S1 2.13 -3.18%
S2 2.11 -4.09%
S3 0 .

FAQ

What is the symbol for Regulus Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Regulus Therapeutics Inc. is RGLS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Regulus Therapeutics Inc. Stock?
The Regulus Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Regulus Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Regulus Therapeutics Inc. Stock?
Regulus Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Regulus Therapeutics Inc. Stock.

What's the current price of Regulus Therapeutics Inc. Stock?
As of the end of day on the Apr 22, 2024, the price of an Regulus Therapeutics Inc. (RGLS) share was $2.20.

What is the 52-week high and low for Regulus Therapeutics Inc. Stock?
The 52-week high for Regulus Therapeutics Inc. Stock is $3.79 and the 52-week low is $1.08.

What is the market capitalization of Regulus Therapeutics Inc. Stock?
As of the Apr 22, 2024, the market capitalization of Regulus Therapeutics Inc. is 144.023M.

When is the next earnings date for Regulus Therapeutics Inc.?
The upcoming earnings date for Regulus Therapeutics Inc. is May 09, 2024.
Click to get the best stock tips daily for free!